|
CCNC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.7491000031965E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.943400E-01 |
| Stage1-vs-Stage3 |
9.605500E-02 |
| Stage1-vs-Stage4 |
1.371930E-04 |
| Stage2-vs-Stage3 |
7.523800E-02 |
| Stage2-vs-Stage4 |
3.082600E-03 |
| Stage3-vs-Stage4 |
4.843700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.08480000116896E-08 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
3.546400E-01 |
| Caucasian-vs-Asian |
4.672800E-01 |
| AfricanAmerican-vs-Asian |
2.819600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.848800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63369318073592E-12 |
| Normal-vs-Age(81-100Yrs) |
2.229600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.615200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.972800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.935800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.343600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.223400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.006600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.203600E-02 |
| Classical-VS-Follicular |
5.76709999999814E-05 |
| Classical-VS-Other |
5.916200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.06899999996468E-06 |
| Tall-VS-Other |
6.850800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.641100E-03 |
| Follicular-VS-Normal |
3.77110000004954E-06 |
| Other-VS-Normal |
3.38860000004271E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.21964677141295E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.382200E-04 |
|
|
